Agile Therapeutics to Join Russell 3000® and 2000® Indexes
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare
company, today announced that the Company will be added to the
Russell 3000® and 2000® Indexes, effective after the U.S. market
opens on June 29, 2020, as part of the Russell Indexes annual
Russell indexes are widely used by investment
managers and institutional investors for index funds and as
benchmarks for active investment strategies. Approximately $9
trillion in assets are benchmarked against Russell’s US indexes.
Russell indexes are part of FTSE Russell, a leading global index
For more information on the Russell 3000® and
2000® Indexes and the Russell indexes reconstitution, go to the
“Russell Reconstitution” section on the FTSE Russell website.
About Agile Therapeutics,
Inc.Agile Therapeutics is a women's healthcare company
dedicated to fulfilling the unmet health needs of today’s women.
Our product candidates are designed to provide women with
contraceptive options that offer freedom from taking a daily pill,
without committing to a longer-acting method. Our initial product,
Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system
is a non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website at
www.agiletherapeutics.com. The Company may occasionally disseminate
material, nonpublic information on the Company’s website.
Follow Agile on LinkedIn and Twitter:
About FTSE RussellFTSE Russell
is a leading global index provider creating and managing a wide
range of indexes, data and analytic solutions to meet client needs
across asset classes, style and strategies. Covering 98% of the
investable market, FTSE Russell indexes offer a true picture of
global markets, combined with the specialist knowledge gained from
developing local benchmarks around the world.
FTSE Russell index expertise and products are
used extensively by institutional and retail investors globally.
Approximately $16 trillion is currently benchmarked to FTSE Russell
indexes. For over 30 years, leading asset owners, asset managers,
ETF providers and investment banks have chosen FTSE Russell indexes
to benchmark their investment performance and create investment
funds, ETFs, structured products and index-based derivatives. FTSE
Russell indexes also provide clients with tools for asset
allocation, investment strategy analysis and risk management.
A core set of universal principles guides FTSE
Russell index design and management: a transparent rules-based
methodology is informed by independent committees of leading market
participants. FTSE Russell is focused on index innovation and
customer partnership applying the highest industry standards and
embracing the IOSCO Principles. FTSE Russell is wholly owned by
London Stock Exchange Group.
For more information, visit
RileyInvestor Relations firstname.lastname@example.org